Synairgen (SNG) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Synairgen

NOTE: This is based on 29 open tips for Synairgen (SNG)


Synairgen (SNG)
Latest Quote Price

2.56p

Synairgen (SNG)
Price Change (%)

3.39%


Latest Bid : 2.02p Latest Ask : 3.09p
High Today : 2.59p Low Today : 2.02p
This Years High : 5.46p This Years Low : 2.00p
Volume : 771,839 MKT Cap : £5.17M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Synairgen (SNG) Overview

In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.

Synairgen (SNG) Latest Tips

Type Tipster SectorScore Start date Performance
Hold Deutsche Bank Premium Only 2024-05-07 06:48:00 07/05/2024 -58.79%
Hold Richard Evans Premium Only 2021-11-10 07:45:00 10/11/2021 -97.43%
Speculative Buy Rupert Hargreaves Premium Only 2021-10-20 11:20:00 20/10/2021 -97.12%
Speculative Buy Rupert Hargreaves Premium Only 2021-06-16 14:25:00 16/06/2021 -96.55%
Watch Richard Evans Premium Only 2021-06-02 08:25:00 02/06/2021 –

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Synairgen (SNG) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 2.02p Latest Ask : 3.09p
High Today : 2.59p Low Today : 2.02p
This Years High : 5.46p This Years Low : 2.00p
Volume : 771,839 MKT Cap : £5.17M

Synairgen Overview

In the 1970s, Synairgen founder, British immunophysician Professor Sir Stephen Holgate, began investigating how respiratory viruses can cause serious illness, with the aim of translating these insights into effective clinical treatments. Joined by fellow University of Southampton professors Donna Davies and Ratko Djukanovic in the 1990s, together the three formed Synairgen in 2003 with the sole aim of bringing these advances to patients.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Synairgen Tips

Type Tipster SectorScore Start date Performance
Hold Deutsche Bank Premium Only 2024-05-07 06:48:00 07/05/2024 -58.79%
Hold Richard Evans Premium Only 2021-11-10 07:45:00 10/11/2021 -97.43%
Speculative Buy Rupert Hargreaves Premium Only 2021-10-20 11:20:00 20/10/2021 -97.12%
Speculative Buy Rupert Hargreaves Premium Only 2021-06-16 14:25:00 16/06/2021 -96.55%
Watch Richard Evans Premium Only 2021-06-02 08:25:00 02/06/2021 –